{"doi":"10.1053/j.seminhematol.2010.01.001","title":"CD20 as a Target for Therapeutic Type I and II Monoclonal Antibodies","abstract":null,"journal":"Seminars in Hematology","year":2010,"id":17376,"datarank":8.5555394253649,"base_score":5.342334251964811,"endowment":5.342334251964811,"self_citation_contribution":0.8013501377947218,"citation_network_contribution":7.754189287570179,"self_endowment_contribution":0.8013501377947218,"citer_contribution":7.754189287570179,"corpus_percentile":null,"corpus_rank":null,"citation_count":208,"citer_count":198,"citers_with_citation_signal":177,"citers_with_endowment":177,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":124564,"name":"Claude H.T. Chan","orcid":null,"position":1,"is_corresponding":false},{"id":124565,"name":"Ruth R. French","orcid":null,"position":2,"is_corresponding":false},{"id":124566,"name":"Mark S. Cragg","orcid":null,"position":3,"is_corresponding":false},{"id":124567,"name":"Martin J. Glennie","orcid":null,"position":4,"is_corresponding":false},{"id":124563,"name":"Stephen A. Beers","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":5.342334251964811,"endowment":5.342334251964811,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"20350657","pmcid":null,"openalex_id":"https://openalex.org/W1973919081","authors":[],"funders":[{"funder_name":"Cancer Research UK","grant_id":"","title":null},{"funder_name":"Medical Research Council","grant_id":"","title":null},{"funder_name":"Cancer Research UK","grant_id":"","title":null},{"funder_name":"Medical Research Council","grant_id":"","title":null}],"total_grants":4,"fwci":14.2021,"citation_percentile":0.99244163,"influential_citations":10,"citation_trend":[{"year":2012,"count":19},{"year":2013,"count":18},{"year":2014,"count":17},{"year":2015,"count":28},{"year":2016,"count":11},{"year":2017,"count":12},{"year":2018,"count":9},{"year":2019,"count":13},{"year":2020,"count":12},{"year":2021,"count":10},{"year":2022,"count":9},{"year":2023,"count":11},{"year":2024,"count":10},{"year":2025,"count":8},{"year":2026,"count":1}],"oa_status":"closed","license":"https://www.elsevier.com/legal/tdmrep-license","oa_locations":[{"url":"https://api.elsevier.com/content/article/PII:S0037196310000028?httpAccept=text/xml","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S0037196310000028?httpAccept=text/plain","host_type":"publisher"},{"url":"https://doi.org/10.1053/j.seminhematol.2010.01.001","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/20350657","host_type":"repository"},{"url":"https://eprints.soton.ac.uk/148173/","host_type":"repository"}],"fields_of_study":["Monoclonal and Polyclonal Antibodies Research","Lymphoma Diagnosis and Treatment","HER2/EGFR in Cancer Research","Medicine","Animals","Antibodies, Monoclonal","Antibodies, Monoclonal, Murine-Derived","Antibody Specificity","Antibody-Dependent Cell Cytotoxicity","Antigen-Antibody Reactions","Antigens, CD20","Antigens, Surface","Antineoplastic Agents","B-Lymphocytes","Calcium Signaling","Cell Death","Drug Delivery Systems","Humans","Lymphoma, B-Cell","Mice","Mice, Transgenic","Protein Conformation","Protein Transport","Rituximab"],"mesh_terms":["Rituximab","Animals","Antibodies, Monoclonal","Antibody Specificity","Antibody-Dependent Cell Cytotoxicity","Antigen-Antibody Reactions","Antigens, Surface","Antineoplastic Agents","B-Lymphocytes","Humans","Mice, Transgenic","Protein Conformation","Lymphoma, B-Cell","Drug Delivery Systems","Cell Death","Antigens, CD20","Calcium Signaling","Protein Transport","Mice","Antibodies, Monoclonal, Murine-Derived"],"keywords":["Rituximab","Monoclonal antibody","CD20","Immunology","Internalization","Cytotoxic T cell","Medicine","Effector","Monoclonal","Lymphoma","Rheumatoid arthritis","Antibody","Cancer research","Biology","Internal medicine","Receptor"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-02T18:36:47.059430Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}